It has been reported that activated AhR aggravates renal damage and mediates CKD complications, including cardiovascular disease, anaemia, bone disorders, cognitive dysfunction and malnutrition, and that it influences drug metabolism in individuals with CKD [55]. The gene discussed is AHR; the disease is anemia (phenotype).